Xeris Biopharma Holdings Inc Asset Turnover Ratio (XERS), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Xeris Biopharma Holdings Inc   (NASDAQ: XERS)
 

Xeris Biopharma Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the second quarter 2026, Xeris Biopharma Holdings Inc 's asset turnover ratio sequentially decreased to 0.8 in the second quarter (Jun 30 2026), but remained above the company's average. For every Dollar on the Balance Sheet, Xeris Biopharma Holdings Inc realized $0.8 in annual sales.

Within sector 37 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 1220, from total ranking in the first quarter 2026 at 1418.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XERS Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 59.45 % 24.27 % 26.16 % 22.62 % 7.49 %
Y / Y Revenue Change 28.74 % 38.27 % 42.78 % 37.06 % 48.84 %
Asset Turnover Ratio (TTM) 0.8 0.85 0.83 0.8 0.78
XERS's Total Ranking # 1220 # 1418 # 1353 # 1433 # 1630
Seq. Asset Change 36.13 % 2.21 % 3.6 % 10.61 % 6.1 %
Seq. Revenue Change 10.79 % -3.12 % 15.36 % 3.97 % 19 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 38
Healthcare Sector # 153
Overall Market # 1220

Asset Turnover Ratio Statistics
High Average Low
0.86 0.4 0
(Jun 30 2026)   (Sep 30 2019)




XERS Company Profile • Back to XERS Efficiency Comparisons • Compare XERS Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Privia Health Group Inc   1.68 $ 2,358.069  Millions$ 1,406.710  Millions
Chemed Corporation  1.65 $ 2,595.001  Millions$ 1,569.302  Millions
Aspira Women s Health inc   1.62 $ 9.029  Millions$ 5.569  Millions
Koru Medical Systems Inc   1.61 $ 45.108  Millions$ 27.964  Millions
Adm Tronics Unlimited Inc   1.59 $ 3.240  Millions$ 2.034  Millions
Qhslab Inc   1.56 $ 3.017  Millions$ 1.932  Millions
Sanara Medtech Inc   1.56 $ 110.116  Millions$ 70.614  Millions
Lftd Partners Inc   1.56 $ 35.335  Millions$ 22.674  Millions
Nephros Inc   1.54 $ 21.686  Millions$ 14.113  Millions
Medinotec Inc   1.52 $ 10.247  Millions$ 6.745  Millions
Marpai Inc  1.51 $ 16.635  Millions$ 11.010  Millions
Meiragtx Holdings Plc  1.48 $ 397.501  Millions$ 268.751  Millions
Evofem Biosciences Inc   1.47 $ 18.045  Millions$ 12.261  Millions
Sonoma Pharmaceuticals Inc   1.47 $ 21.920  Millions$ 14.904  Millions
Infusystem Holdings Inc  1.45 $ 143.335  Millions$ 98.950  Millions
Medpace Holdings Inc   1.41 $ 2,782.288  Millions$ 1,978.819  Millions
Evolus Inc   1.39 $ 317.113  Millions$ 228.384  Millions
Avita Medical Inc   1.38 $ 75.631  Millions$ 54.860  Millions
Edap Tms Sa  1.37 $ 111.051  Millions$ 81.022  Millions
Idexx Laboratories Inc  1.34 $ 4,553.792  Millions$ 3,391.326  Millions
Vaxart Inc   1.31 $ 243.064  Millions$ 185.077  Millions
Karyopharm Therapeutics Inc   1.31 $ 146.621  Millions$ 111.845  Millions
Aveanna Healthcare Holdings Inc   1.31 $ 2,602.820  Millions$ 1,987.815  Millions
Tactile Systems Technology Inc   1.29 $ 350.319  Millions$ 271.226  Millions
Lifeloc Technologies Inc   1.29 $ 9.269  Millions$ 7.201  Millions
Precipio inc   1.29 $ 27.198  Millions$ 21.149  Millions
Interpace Biosciences Inc   1.28 $ 36.519  Millions$ 28.458  Millions
Exagen Inc   1.27 $ 71.427  Millions$ 56.184  Millions
Warby Parker Inc   1.24 $ 912.542  Millions$ 734.141  Millions
Electromed Inc   1.24 $ 72.076  Millions$ 58.289  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.